Skip to content
Primary Navigation Menu
Menu
  • Company
    • Mission & Vision
    • Leadership
    • R&D Key Members
    • Scientific Advisory Board
    • Location
  • BRIXELLE Platform
  • OPTA Platform
    • BRIXELLE Platform
    • BRIXELLE-INFLA
    • BRIXELLE-ONCO
    • BRIXELLE-SHINE
    • Publications
    • Patents
  • Pipeline
  • News
  • Event
  • Contact

Bilix (Page 4)

Bilix Ltd aiming to prevent inflammatory disease that cause heart attacks

2019-10-25
By: Bilix
On: October 25, 2019
In: News

Bilix Ltd CEO Myung Kim sat down with Proactive at the 2019 BIO Investor Forum in San Francisco. Kim says when patients are struck with a heart attacks, 40% ofRead More →

‘페길화 빌리루빈 나노의약’ 항염증 및 항암 치료 원천기술

2019-03-29
By: Bilix
On: March 29, 2019
In: News

창간 65주년 특집 ‘카이스트 제약바이오 10대 유망기술’ 생명과학과 전상용 교수 연구팀 우리 몸속에 존재하는 ‘빌리루빈(bilirubin)’은 Heme 최종 대사물로 황달유발물질로 수십 년 전까지만 해도 간접적인 간담도 질환의 증거로 인식돼 백해무익한 물질로만Read More →

Posts pagination

Previous 1 … 3 4
arrow_upward

Bldg. C-Suite 604, 338, Gwanggyojungang-ro, Suji-gu, Yongin, Gyeonggi 16942, South Korea.
Tel: +82.31.212.0961 Fax: +82.31.212.0964

  • my_location Location
  • email Contact us

Copyright© BILIX.Co., Ltd. All Rights Reserved.